Find the latest Protalix BioTherapeutics, Inc. (PLX) stock quote, history, news and other vital information to help you with your stock trading and. Protalix BioTherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker PLX. The last closing price for. Shares of Protalix BioTherapeutics (AMEX:PLX) were gapping down Tuesday morning with an open price % lower than Monday's closing price. The stock closed at. Protalix BioTherapeutics (AMEX:PLX) Stock Quotes, Forecast and News Summary ; 52 Wk Range, - ; Market Cap, $M ; P/E Ratio, - ; Dividend Yield, -. SuperCom Ltd. Ordinary Shares. $ SPCB % ; BioLine RX Ltd - ADR. $ BLRX % ; Can Fite Biopharma ADR Representing Ord Shs. $ CANF %.
Protalix BioTherapeutics Inc. PLX Overview · Market Cap · P/E Ratio (ttm) · Beta · Volume · Dividend & Yield. News for Protalix Biotherapeutics Stock (PLX) · Protalix BioTherapeutics, Inc. · Protalix BioTherapeutics Reports Second Quarter Financial and Business. Get Protalix Biotherapeutics Inc (PLX:NYSE American) real-time stock quotes, news, price and financial information from CNBC. The average one-year price target for Protalix BioTherapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. (NYSEMKT: PLX) Protalix Biotherapeutics stock price per share is $ today (as of Aug 23, ). What is Protalix Biotherapeutics's Market Cap. View Protalix Biotherapeutics, Inc. PLX stock quote prices, financial information, real-time forecasts, and company news from CNN. PLX Protalix BioTherapeutics Inc. 16, $ $ (%). Today. Watchers, 16, Wk Low, $ Wk High, $ Market Cap, $M. No significant news for PLX in the past two years. COMPETITORS (PLX). Company, Change. Complete Protalix BioTherapeutics Inc. stock information by Barron's. View real-time PLX stock price and news, along with industry-best analysis. Protalix BioTherapeutics Inc stock price ended at $ on Thursday, after gaining %. (Updated on Sep 05, ) · % during the next 3 months and, with. Stay up-to-date on Protalix BioTherapeutics, Inc. (DE) Common Stock (PLX) news with the latest updates, breaking headlines, news articles, and more from.
One share of PLX stock can currently be purchased for approximately $ Is Protalix BioTherapeutics, Inc. a publicly traded stock? Yes. The biopharmaceutical company's shares were down 11% at $ in recent premarket trading, reflecting. The current price of PLX is USD — it has increased by % in the past 24 hours. Watch Protalix BioTherapeutics, Inc. (DE) stock price performance more. News · Protalix BioTherapeutics Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results. BenzingaAug 14 · Protalix. (DE) Common Stock (PLX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. View the real-time PLX price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees. Earnings are forecast to grow % per year · Trading at good value compared to peers and industry · Shareholders have been diluted in the past year · Does not. Protalix (PLX) Stock Price & Analysis ; Price to Book (P/B) ; Price to Sales (P/S) ; Price to Cash Flow (P/CF) ; P/FCF Ratio ; Enterprise Value/. Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical company specializing in recombinant therapeutic proteins, has announced its participation in.
Protalix BioTherapeutics Inc Stock News from GuruFocus · Protalix BioTherapeutics Inc (PLX) Q2 Earnings Call Transcript Highlights: Revenue Decline and. Get Protalix Biotherapeutics Inc (PLX) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Protalix BioTherapeutics Inc (PLX) reported a net income of $ million for Q3 , a significant improvement from a loss of $ million in the same. News for Protalix Biotherapeutics Stock (PLX) · Protalix BioTherapeutics Stock: FDA Approval For Elfabrio To Drive Profitability · Protalix BioTherapeutics Issues. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM) · Market Cap M · Shares Outstanding. M · Public Float. M · Yield. PLX is not currently.
Stock information. Stock Quote & Chart · Historic Price Lookup · Investment ALL NEWS. Skip to content. 14 Aug. Protalix BioTherapeutics Reports Second. Protalix Biotherapeutics Inc News & Analysis · Protalix BioTherapeutics Repays Outstanding Senior Secured Convertible Promissory Notes · Earnings call: Protalix. Earnings Date. 01/01/ EPS EST. EPS PRIOR. EPS. Rev guidance. $10,,, PLX Stock Price. Upcoming PLX Catalysts. Drug. Stage.
Affordable Oceanfront Homes In California | Top Learning Toys For 1 Year Olds